Literature DB >> 6304105

Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

H Majewski.   

Abstract

On peripheral noradrenergic nerve endings there exist beta-adrenoreceptors activation of which results in an enhanced release of noradrenaline in response to nerve stimulation. These presynapatic beta-adrenoreceptors do not appear to be activated by neuronally-released noradrenaline. However, adrenaline may be a physiological activator during enhanced adrenomedullary secretion. Adrenaline can also be incorporated into the noradrenergic transmitter stores and be released as a co-transmitter. Under these conditions presynaptic beta-adrenoreceptors may be activated by neuronally-released adrenaline, thus forming a 'positive feedback loop'. The release of adrenaline from the adrenal medullae may also be modulated through facilitatory beta-adrenoreceptors, but the release of noradrenaline from noradrenergic nerves in the central nervous system is not. The facilitatory presynaptic beta-adrenoreceptors appear to be in the main of the beta 2-subtype although precise receptor characterization has not been carried out. Increased activation of presynaptic beta-adrenoreceptors by adrenaline may be implicated in the development of essential hypertension. Part of the antihypertensive action of beta-adrenoreceptor blocking drugs may be due to blockade of these facilitatory presynaptic beta-adrenoreceptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304105     DOI: 10.1111/j.1474-8673.1983.tb00496.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  54 in total

1.  Effect of isoprenaline on noradrenaline release from sympathetic neurones in rabbit isolated pulmonary artery.

Authors:  O A Nedergaard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

Review 2.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

3.  Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors.

Authors:  K D Murugaiah; J M O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

4.  Beta-adrenergic blood pressure regulation in Shy-Drager syndrome and pheochromocytoma.

Authors:  M Middeke; J Ittner; M Mezger; S Reder; J Remien
Journal:  Klin Wochenschr       Date:  1989-10-02

5.  Beta-adrenoceptor-mediated facilitation of endogenous noradrenaline release from rat isolated trachea.

Authors:  G Brunn; I Wessler; G P Anderson; J Maclagan; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Evidence for tonic activation of prejunctional beta-adrenoceptors in guinea-pig pulmonary arteries by adrenaline derived from the adrenal medulla.

Authors:  Y Misu; M Kuwahara; H Amano; T Kubo
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex.

Authors:  E Schlicker; M Göthert; K Hillenbrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

8.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

9.  Pre- and postganglionic stimulation-induced noradrenaline overflow is markedly facilitated by a prejunctional beta 2-adrenoceptor-mediated control mechanism in the pithed rat.

Authors:  V I Tarizzo; R P Coppes; C Dahlöf; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

10.  Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.

Authors:  S Guimarães; A Albino-Teixeira; M Q Paiva
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.